0001125345-24-000021.txt : 20240212 0001125345-24-000021.hdr.sgml : 20240212 20240212173222 ACCESSION NUMBER: 0001125345-24-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Risser Eric Blasius CENTRAL INDEX KEY: 0001587774 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 24621519 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wk-form4_1707777132.xml FORM 4 X0508 4 2024-02-08 0 0001125345 MACROGENICS INC MGNX 0001587774 Risser Eric Blasius 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 Chief Operating Officer 0 Employee Stock Option (right to buy) 18.30 2024-02-08 4 A 0 90000 0 A 2034-02-08 Common Stock 90000 90000 D Restricted Stock Unit 2024-02-08 4 A 0 33500 0 A Common Stock 33500 33500 D 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. /s/ Lynn M. Cilinski, Attorney-in-fact 2024-02-12